1. Market Research
  2. > Pharmaceutical
  3. > OTC Market Trends

Global Market Study on Dermatophytic Onychomycosis Therapeutics (DOT): North America Expected to Account for Maximum Market Share by 2021, Due to Increasing Prevalence of Fungal Toe Nail Infections

  • August 2016
  • 183 pages
  • Persistence Market Research
Report ID: 3658142

Summary

Table of Contents

Dermatophytic onychomycosis is a fungal nail infection caused by dermatophytes. Dermatophytic onychomycosis is also known as tinea unguium. It is called the dermatophytic invasion of the nail plate. It is the most common nail infection and constitutes more than half of all nail disease cases. This condition mostly affects toenails. The overall prevalence rate of dermatophytic onychomycosis is around 10% in the general population. The disease can lead to severe pain and can impede work and social activities.

This report covers the global dermatophytic onychomycosis therapeutics market performance in terms of revenue contribution. The report includes key trends, drivers, restraints, and opportunities influencing the growth of the global dermatophytic onychomycosis therapeutics market. Impact analysis of key growth drivers and restraints, based on the weighted average model, are included to better equip clients with crystal clear decision-making insights.

The global dermatophytic onychomycosis therapeutics market is mainly driven by factors such as increasing the prevalence of dermatophytic onychomycosis, rising aging population, increasing consumer inclination towards maintaining aesthetic appearance of nails, and increasing per capita healthcare expenditure. Potential side effects of therapeutic products, availability of alternative treatments, and lack of awareness in emerging regions such as APEJ and MEA are expected to hinder the growth of the dermatophytic onychomycosis therapeutics market.

On the basis of products, dermatophytic onychomycosis therapeutics market is segmented into tablet and nail paint. Both the segments, tablet and nail paint are further sub-segmented into prescription and over-the-counter products. By distribution channel, dermatophytic onychomycosis therapeutics market is segmented into hospitals, clinics, independent pharmacies, mail order pharmacies, and drug stores.

By product, revenue from the tablet segment is projected to rise at the highest CAGR of 5.2% during the forecast period. The nail paint segment is expected to dominate the market, accounting for a maximum share of the overall market by 2021. The nail paint segment revenue is projected to rise at a CAGR of 8.3% during the forecast period (2015–2021).

By treatment, the topical segment is estimated to dominate the dermatophytic onychomycosis therapeutics market, accounting for a maximum share of the overall market by 2015 end. Revenue from the topical segment is projected to increase at a CAGR of 8.3% during the forecast period.

In terms of value, North America dominated the market with over 43% market share in 2014, followed by Europe. In Asia Pacific, this market is projected to expand at the highest CAGR of 5.1% during the forecast period.

Key players of the global dermatophytic onychomycosis therapeutics market are Valeant Pharmaceuticals International Inc., Galderma S.A., Novartis AG, Pfizer Inc., Moberg Pharma AB, Johnson & Johnson Services, Inc., and Anacor Pharmaceuticals, Inc. Leading players operating in the market collaborate with healthcare solutions and services providers in order to advance operational efficiencies and provide improved patient care.

The dermatophytic onychomycosis therapeutics market is segmented as follows:

By Product:
Tablet
Prescription (Rx.)
Over-the-counter
Nail Paint
Prescription (Rx.)
Over-the-counter
By Treatment:
Oral
Topical
By Distribution Channels:
Hospitals
Clinics
Independent Pharmacies
Mail Order Pharmacies
Drug Stores
By Region:
North America
U.S.
Canada
Europe
Germany
Italy
France
U.K.
Spain
Rest of Europe
Asia pacific
China
India
Japan
Australia & New Zealand
Rest of Asia Pacific
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
MEA
GCC Nations
South Africa
Rest of MEA

Key features included in this report:
Drivers and restraints of the dermatophytic onychomycosis therapeutics market
Latest product innovations and key developments in the market
Analysis of business strategies of the top players
Dermatophytic onychomycosis therapeutics market estimates and forecasts

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

Veronica helps you find the right report:

Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers

Antifungal Drugs: Technologies and Global Markets

  • $ 6650
  • Industry report
  • March 2017
  • by BCC Research

Use this report to: - Evaluate the effect of strategic factors such as technology-driven change and industry consolidation on the antifungal drugs market. - Investigate the current market dynamics and ...

Dermatophytic Onychomycosis- Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • March 2017
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Dermatophytic Onychomycosis - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease ...

Antifungal Drugs - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • February 2017
  • by Stratistics MRC

“According to Stratistics MRC, the Global Antifungal Drugs Market is accounted for $13.2 billion in 2016 and is expected to reach $18.2 billion by 2022 growing at a CAGR of 5.4% during the forecast period”. ...


Download Unlimited Documents from Trusted Public Sources

Antifungal Industry in the US

  • April 2017
    4 pages
  • Antifungal  

  • United States  

    China  

View report >

OTC Industry in the US

  • March 2017
    29 pages
  • Prostate Cancer  

    Clinical Trial  

    Therapy  

  • United States  

View report >

Gastrointestinal Drug Industry in Canada

  • March 2017
    92 pages
  • Gastrointestina...  

    Health Care Pro...  

    Ambulatory Care  

  • Canada  

    North America  

View report >

Otc Industry In India

5 months ago

Antiseptics Markets

6 months ago

Related Market Segments :

Antifungal
Infectious Disease

ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.